A consensus statement on health-care transition for childhood-onset inflammatory bowel disease patients

Hideki Kumagai1, Toshiaki Shimizu2, Itaru Iwama3

  • 1Department of Pediatrics, Jichi Medical University, Shimotsuke, Tochigi, Japan.

Insights

Childhood-onset inflammatory bowel disease (IBD) requires planned healthcare transition. Consensus statements were developed to improve care coordination between pediatric and adult gastroenterologists for these patients.

Area of Science:

  • Gastroenterology
  • Pediatric Medicine
  • Health Services Research

Background:

  • Inflammatory bowel disease (IBD) is a chronic intestinal inflammatory disorder with increasing global incidence.
  • A significant portion of IBD cases are diagnosed in childhood (before 18 years), necessitating lifelong management.
  • Existing knowledge and perception gaps exist between Japanese pediatric and adult gastroenterologists regarding healthcare transition for childhood-onset IBD.

Purpose of the Study:

  • To address the challenges in healthcare transition for patients with childhood-onset IBD in Japan.
  • To develop consensus statements for improving the transfer process from pediatric to adult care.
  • To establish guidelines for effective transitional care programs for IBD patients.

Main Methods:

  • A panel of experienced pediatric and adult gastroenterologists convened through web workshops.
  • Discussions focused on issues related to transitional care for IBD patients.
  • Consensus statements were formulated based on expert discussions.

Main Results:

  • Five consensus statements were developed regarding the transfer from pediatric to adult care.
  • Nine consensus statements were established concerning the implementation of transitional care programs.
  • The consensus addresses critical aspects of managing IBD patients transitioning to adult services.

Conclusions:

  • A programmed approach to transition and enhanced collaboration between pediatric and adult gastroenterologists are crucial.
  • The developed consensus statements aim to bridge current gaps in healthcare transition for childhood-onset IBD.
  • This consensus is intended to form the basis for future clinical practice guidelines.

Related Concept Videos

Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
175
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
401
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
200
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
367
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
197
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
534